Proven efficacy of OxiLast against the new fungal threat: Candida Auris

At Prof. Moran-Gilad Lab At The Ben-Gurion University

Under the tested lab conditions, OxiLast formulation have a Proven efficacy against:
Escherichia coli (abbreviated as E. coli)
Methicillin-resistant Staphylococcus aureus (MRSA) 3359, and hospital isolates
Vancomycin-resistant Enterococcus faecalis (VRE) 51299
Carbapenem resistant Klebsiella pneumoniae (CRE) BAA-1705, and hospital isolates.
Pseudomonas aeruginosa 9027
Acinetobacter baumannii 19606.
≥99.99% reduction of all the above strains within 5-15 min, up to 7 days

Activity under challenging conditions:
≥99.99% reduction of all the above strains within 5-15 min, up to 7 days, in presence of organic contamination; artificial test soil (ATS) or bovine serum albumin (BSA)
5-cycles of dry abrasion
2 successive bacterial loadings

“As an expert in this field,
I believe this technology can be a game changer in the prevention of resistant infections.”
Jacob Moran-Gilad
Prof. of Public Health and Clinical Microbiology